Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6848621 | PMC |
http://dx.doi.org/10.1007/s11606-019-05157-6 | DOI Listing |
J Antimicrob Chemother
January 2025
Department of Infectious Diseases and Clinical Microbiology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Objectives: To develop a scoring system to predict resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa strains isolated from respiratory specimens.
Methods: A case-control study was conducted to evaluate the risk factors associated with resistance to ceftolozane/tazobactam. Patients with P.
Environ Sci Pollut Res Int
January 2025
Department of Instrumentation and Control Engineering, Manipal Institute of Technology, Manipal Academy of Higher Education, Manipal, Karnataka, India.
Ciprofloxacin (CIP) is an extensively used broad-spectrum, fluoroquinolone antibiotic used for treating diverse bacterial infections. Effluent treatment plants (ETPs) worldwide lack technologies to detect or remediate antibiotics. CIP reaches the aquatic phase primarily due to inappropriate disposal practices, lack of point-of-use sensing, and preloaded activated charcoal filter at ETPs.
View Article and Find Full Text PDFInt J Mol Sci
December 2024
Department of Biology of Bacteria, Institute of Microbiology, Biotechnology and Immunology, Faculty of Biology and Environmental Protection, University of Lodz, 90-237 Lodz, Poland.
The widespread and inappropriate use of antibiotics, for therapeutic and prophylactic purposes, has contributed to a global crisis of rapidly increasing antimicrobial resistance of microorganisms. This resistance is often associated with elevated mutagenesis induced by the presence of antibiotics. Additionally, subinhibitory concentrations of antibiotics can trigger stress responses in bacteria, further exacerbating this problem.
View Article and Find Full Text PDFMikrobiyol Bul
October 2024
Hacettepe University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Ankara, Türkiye.
A sexually transmitted bacterium, Mycoplasma genitalium has varying rates of reported resistance to macrolide and some fluoroquinolone group antimicrobials recommended for the treatment of its infections. It is currently recommended that the treatment of these must be planned according to macrolide resistance status. The aim of this study was to determine the presence of macrolide resistance associated mutations (MRM) and fluoroquinolone resistance associated mutations (QRM) in patients infected with M.
View Article and Find Full Text PDFAm J Health Syst Pharm
December 2024
College of Pharmacy, Roseman University of Health Sciences, Henderson, NV, and Reserve Commissioned Corps, United States Public Health Service, Washington, DC, USA.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!